3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
36
Phase 1
18
Phase 1/2
10
Phase 3
8
Phase EARLY_PHASE1
4
Phase 4
3
Phase NA
2
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
3
Conditions
Breast Neoplasms
3
Interventions
Dexamethasone
49
Metformin
47
Cyclophosphamide
42
Saline Solution
38
Cytarabine
34
Sodium Chloride
32
Bupivacaine
31
Vincristine
27
Cisplatin
26
Propofol
25
Methotrexate
25
Letrozole
24
Fluorouracil
24
Dexmedetomidine
24
Doxorubicin
23
Fentanyl
22
Carboplatin
22
Etoposide
19
Rituximab
18
Morphine
18
Bevacizumab
18
Acetaminophen
18
Lidocaine
17
Granulocyte Colony-Stimulating Factor
17
Prednisone
16
Mercaptopurine
16
Docetaxel
16
Clomiphene
16
Sevoflurane
15
Ropivacaine
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER
×
ribociclib
×
Clear all
NCT07487129
2026-03-23
Clinical and P
Beni-Suef University
Phase 4
Completed
206 enrolled
NCT04657679
2024-11-26
LEANORA
Georgetown University
Phase 4
Terminated
21 enrolled
19 charts
NCT05452213
2023-04-18
CAPTOR-BC
Institut fuer Frauengesundheit
Phase 4
Recruiting
1,000 enrolled